Orchestra BioMed Holdings annual operating expenses
2020
2022
2023
2024
2025
Orchestra BioMed Holdings Operating Expenses Growth & History (OBIO)
Orchestra BioMed Holdings's operating expenses was $85.3M for fiscal 2025.
View full Orchestra BioMed Holdings company overviewOrchestra BioMed Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $85.3M | $18.4M | +27.41% |
| 2024 | 2024-12-31 | $66.9M | $12.7M | +23.35% |
| 2023 | 2023-12-31 | $54.3M | $18.1M | +49.95% |
| 2022 | 2022-12-31 | $36.2M | — | — |
| 2020 | 2020-12-31 | $179,986 | — | — |
Orchestra BioMed Holdings quarterly operating expenses
Q3.20
Q1.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $22.4M | $2.3M | +11.31% |
| Q1 2026 | 2026-03-31 | $22.2M | $2.4M | +12.11% |
| Q4 2025 | 2025-12-31 | $24.2M | $7.2M | +42.72% |
| Q3 2025 | 2025-09-30 | $21.2M | $3.8M | +22.19% |
| Q2 2025 | 2025-06-30 | $20.2M | $2.5M | +14.32% |
| Q1 2025 | 2025-03-31 | $19.8M | $4.7M | +31.55% |
| Q4 2024 | 2024-12-31 | $16.9M | $4.2M | +32.86% |
| Q3 2024 | 2024-09-30 | $17.3M | $2.4M | +15.97% |
| Q2 2024 | 2024-06-30 | $17.6M | $3.8M | +27.15% |
| Q1 2024 | 2024-03-31 | $15.0M | $2.3M | +18.36% |
| Q4 2023 | 2023-12-31 | $12.7M | $1.8M | +16.58% |
| Q3 2023 | 2023-09-30 | $14.9M | $3.7M | +33.06% |
| Q2 2023 | 2023-06-30 | $13.9M | $5.8M | +72.63% |
| Q1 2023 | 2023-03-31 | $12.7M | $6.7M | +112.03% |
| Q4 2022 | 2022-12-31 | $10.9M | — | — |
| Q3 2022 | 2022-09-30 | $11.2M | — | — |
| Q2 2022 | 2022-06-30 | $8.0M | — | — |
| Q1 2022 | 2022-03-31 | $6.0M | $5.9M | +5254.27% |
| Q1 2021 | 2021-03-31 | $111,948 | — | — |
| Q3 2020 | 2020-09-30 | $68,625 | — | — |
Orchestra BioMed Holdings operating expenses trends
Over the last five fiscal years, Orchestra BioMed Holdings's operating expenses increased from $179,986 to $85.3M, a change of $85.1M. The latest reported quarter, Q2 2026, shows $22.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orchestra BioMed Holdings source filings ↗